Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 103 results:
Author Title [ Type] Year Filters: Keyword is Antineoplastic Combined Chemotherapy Protocols [Clear All Filters]
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia..
Cancer Cell. 28(1), 29-41.
(2015). AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer..
Clin Colorectal Cancer. 17(4), e631-e637.
(2018). Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1..
Anticancer Res. 29(2), 737-44.
(2009). The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping..
Breast. 23(3), 234-43.
(2014). Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab..
Clin Colorectal Cancer. 18(4), e370-e384.
(2019). Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma..
Br J Dermatol. 170(4), 809-15.
(2014). Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis..
Eur J Haematol. 98(6), 563-568.
(2017). Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis..
Am J Hematol. 91(5), 499-502.
(2016). Carboplatin and paclitaxel in metastatic or recurrent cervical cancer..
Int J Gynecol Cancer. 19(4), 777-81.
(2009). Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study..
Clin Lung Cancer. 11(1), 30-5.
(2010). Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)..
Crit Rev Oncol Hematol. 76(1), 61-70.
(2010). Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study..
PLoS One. 11(10), e0164013.
(2016). Current treatment of colorectal liver metastases..
Tech Coloproctol. 8 Suppl 1, s174-6.
(2004). Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome..
Cancer Genet. 206(3), 63-72.
(2013). Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study..
Blood. 126(11), 1392-4.
(2015). Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: not always an easy task..
Int J Hematol. 90(2), 226-9.
(2009). Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel..
PLoS One. 7(6), e37946.
(2012). Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group..
Anticancer Res. 34(10), 5649-55.
(2014). Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study..
Cancer Chemother Pharmacol. 69(2), 477-84.
(2012). Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)..
Breast Cancer Res Treat. 148(3), 591-7.
(2014).
(2014). Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy..
Eur J Cancer. 46(8), 1359-64.
(2010). Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial..
Ann Oncol. 20(2), 278-85.
(2009). Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy..
Anticancer Res. 29(2), 693-702.
(2009).
(2010).